<DOC>
	<DOCNO>NCT02115958</DOCNO>
	<brief_summary>Most study cancer stem cell ( CSC ) involve inoculation cell human tumor immunosuppressed mouse , prevent assessment immunologic interaction effect CSCs . In study , investigator examine vaccination effect produce CSC-enriched population histologically distinct murine tumor inoculation different syngeneic immunocompetent host . Enriched CSCs immunogenic effective antigen source unselected tumor cell induce protective antitumor immunity.Immune sera CSC-vaccinated host contain high level IgG bound CSCs , result CSC lysis presence complement.CTLs generate peripheral blood mononuclear cell splenocytes harvest CSC-vaccinated host capable kill CSCs vitro . Mechanistic investigation establish CSC-primed antibody T cell capable selective target CSCs confer antitumor immunity .</brief_summary>
	<brief_title>The Immunotherapy Nasopharyngeal Cancer Using Cancer Stem Cells Vaccine</brief_title>
	<detailed_description>To assess feasibility generate CSC-loaded DC vaccine clinical use , investigator harvest peripheral blood tumor specimen patient Nasopharyngeal Cancer . The investigator purify T , B cell generate DCs PBMCs nasopharyngeal cancer patient.On hand , investigator isolate ALDHhigh ALDHlow tumor cell tumor specimen nasopharyngeal cancer patient use similar protocol investigator report . Aim 1 : To demonstrate , vitro , relative cellular anti-nasopharyngeal cancer CSC immunity induce nasopharyngeal cancer CSC-DC prim cytotoxic T cell . Aim 2 : To determine , vitro , specific bind lysis nasopharyngeal cancer CSCs antibody produce purified B cell PBMCs stimulate nasopharyngeal cancer CSC-DC .</detailed_description>
	<mesh_term>Lung Neoplasms</mesh_term>
	<mesh_term>Vaccines</mesh_term>
	<criteria>1.patients great 18 year age , advance local disease ( T3T4N01M0 ) , nodal disease ( T1T2N23M0 ) locoregional disease ( T3T4N23M0 ) onset presently control standard therapy ( combination chemotherapy radiotherapy ) completely resect metastatic disease . 2.Pathologic confirmation nasopharyngeal carcinoma NCI Laboratory Pathology ( NPC ) . 3.serum creatinine 2.0 mg/dl less . 4.Total bilirubin 1.6 mg/dl less , except patient Gilbert 's Syndrome must total bilirubin less 3.0 mg/dl . 5.WBC 3000/mm ( 3 ) great . 6.platelet count 90,000 mm ( 3 ) great . 7.serum AST/ALT less three time normal . 8.ECOG performance status 0 1 . 9.Patients gender must willing practice effective birth control trial potential teratogenic effect unknown . 10.Patients may prior adjuvant treatment may treatment metastatic disease evidence disease , include chemotherapy biotherapy , long 1 month elapse since prior systemic therapy . 1 . Patients test positive Hepatitis B virus , Hepatitis C virus HIV . 2. level 3 hypertension ; 3. severe coronary disease ; 4. myelosuppression ; 5. respiratory disease ; 6. brain metastasis ; 7. chronic infection</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>April 2014</verification_date>
</DOC>